Related Experiment Video
Updated: Mar 15, 2026
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis
Katherine A Sanders1, Miles C Benton2, Rod A Lea3
1Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland 4226 Australia ; Centre for Information-Based Medicine, Hunter Medical Research Institute, Newcastle, New South Wales 2305 Australia ; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales 2308 Australia.
Background:
Immunoactivation is less evident in secondary progressive MS (SPMS) compared to relapsing-remitting disease. MicroRNA (miRNA) expression is integral to the regulation of gene expression; determining their impact on immune-related cell functions, especially CD4+ T cells, during disease progression will advance our understanding of MS pathophysiology. This study aimed to compare miRNA profiles of CD4+ T cells from SPMS patients to healthy controls (HC) using whole miRNA transcriptome next-generation sequencing (NGS). Total RNA was extracted from CD4+ T cells and miRNA expression patterns analyzed using Illumina-based small-RNA NGS in 12 SPMS and 12 HC samples. Results were validated in a further cohort of 12 SPMS and 10 HC by reverse transcription quantitative polymerase chain reaction (RT-qPCR).
Results:
The ten most dysregulated miRNAs identified by NGS were selected for qPCR confirmation; five (miR-21-5p, miR-26b-5p, miR-29b-3p, miR-142-3p, and miR-155-5p) were confirmed to be down-regulated in SPMS (p < 0.05). SOCS6 is targeted by eight of these ten miRNAs. Consistent with this, SOCS6 expression is up-regulated in SPMS CD4+ T cells (p < 0.05). This is of particular interest as SOCS6 has previously been shown to act as a negative regulator of T cell activation.
Conclusions:
Ninety-seven percent of miRNA candidates identified by NGS were down-regulated in SPMS. The down-regulation of miRNAs and increased expression of SOCS6 in SPMS CD4+ T cells may contribute to reduced immune system activity in progressive MS.
Insights
MicroRNA (miRNA) levels are altered in progressive multiple sclerosis (MS) CD4+ T cells, with key miRNAs down-regulated and SOCS6 up-regulated, potentially reducing immune activity in secondary progressive MS (SPMS).
Area of Science:
- Immunology
- Genetics
- Neuroscience
Background:
- Secondary progressive multiple sclerosis (SPMS) exhibits reduced immunoactivation compared to relapsing-remitting MS.
- MicroRNAs (miRNAs) are crucial regulators of gene expression impacting immune cell function.
- Understanding miRNA roles in CD4+ T cells during MS progression is vital for elucidating pathophysiology.
Purpose of the Study:
- To compare miRNA expression profiles in CD4+ T cells from SPMS patients and healthy controls (HC).
- To investigate the impact of miRNA dysregulation on immune cell function in progressive MS.
Main Methods:
- Whole miRNA transcriptome analysis using next-generation sequencing (NGS) on CD4+ T cells from SPMS and HC.
- Validation of key miRNA candidates using reverse transcription quantitative polymerase chain reaction (RT-qPCR).
Main Results:
- Five specific miRNAs (miR-21-5p, miR-26b-5p, miR-29b-3p, miR-142-3p, miR-155-5p) were significantly down-regulated in SPMS CD4+ T cells.
- Suppressor of cytokine signaling 6 (SOCS6) expression was significantly up-regulated in SPMS CD4+ T cells.
- SOCS6, a negative regulator of T cell activation, is targeted by eight of the identified dysregulated miRNAs.
Conclusions:
- A significant down-regulation of miRNAs and up-regulation of SOCS6 in SPMS CD4+ T cells were observed.
- These molecular changes may contribute to the diminished immune system activity characteristic of progressive MS.
- Findings highlight potential therapeutic targets for modulating immune responses in SPMS.
